K123319 is an FDA 510(k) clearance for the GYRUS ACMI BICOAG HEMOSTASIS PROBE. Classified as Unit, Electrosurgical, Endoscopic (with Or Without Accessories) (product code KNS), Class II - Special Controls.
Submitted by Olympus Surgical Technologies America (Southborough, US). The FDA issued a Cleared decision on December 14, 2012 after a review of 49 days - a notably fast clearance cycle.
This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.4300 - the FDA gastroenterology and urology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.
View all Olympus Surgical Technologies America devices